Clinical Trial Update: Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing long-term versus conventional rituximab maintenance in ANCA-associated vasculitis has completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: ANCA-associated Vasculitides | Phase 3 | Status: COMPLETED